Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts

NCT01241500

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Virginia G. Piper Cancer Center Scottsdale, Arizona, United States
  • University of California San Diego Moores Cancer Center La Jolla, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 87 locations
View Trial Details
Completed

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

NCT01928537

Conditions
Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +17 more
Locations
  • Stanford University Cancer Center Stanford, California, United States
  • Rush University Medical Center Chicago, Illinois, United States
  • University of Chicago Medicine Chicago, Illinois, United States
  • University of Kansas Cancer Center and Medical Pavilion Westwood, Kansas, United States
View all 35 locations
View Trial Details
Completed

Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies

NCT02223052

Conditions
Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
Locations
  • Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Completed

A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 Status

NCT00462761

Conditions
AML, Acute Myeloid Leukemia, Aortic aneurysm, familial thoracic 4, +18 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
  • MD Anderson Cancer Center Houston, Texas, United States
  • Chemotherapy and Immunotherapy Clinic Tbilisi, Georgia
View Trial Details
Completed

Treosulfan-based Conditioning in Paediatric Patients With Haematological Malignancies

NCT02333058

Conditions
Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), Bone Marrow Diseases, +5 more
Locations
  • St. Anna Children Hospital Vienna, Austria
  • University Hospital Motol, Charles University, Prague Prague, Czechia
  • University Clinic Düsseldorf Düsseldorf, Germany
  • University Clinic Erlangen-Nürnberg Erlangen, Germany
View all 24 locations
View Trial Details
Completed

A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)

NCT02145026

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations
  • King Chulalongkorn Memorial Hospital; Division of Hematology, Department of Medicine Bangkok, Thailand
  • Rajavithi Hospital; Medicine Bangkok, Thailand
  • Ramathibodi Hospital; Division of Hematology, Department of Medicine Bangkok, Thailand
  • Siriraj Hospital; Division of Hematology, Department of Medicine Bangkok, Thailand
View Trial Details

Related conditions